Spectrum Clinical Research Private Limited

Spectrum Clinical Research Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U73200MH2006PTC162777 Incorporated 22 June 2006 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2024
₹7.52 Cr
▲ 19% YoY
Net loss · FY 2024
₹2.61 Cr
Net margin -34.7%
EBITDA · FY 2024
-₹2.13 Cr
EBITDA margin -28.4%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹49.53 Lakh
Satisfied ₹85.28 Lakh
Company age
20 yrs
Est. 2006
Directors on board
2
As per MCA filings

About Spectrum Clinical Research Private Limited

Data last updated:

Spectrum Clinical Research Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 22 June 2006 and has been in existence for over 20 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U73200MH2006PTC162777. Its GSTIN is 27AAKCS0174Q1ZQ (Maharashtra).

The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Vimal Chandubhai Gadhiya and Viral Chittaranjan Shah.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 501 5th Floor 37 Kshamalaya New Marine Lines, Mumbai, Maharashtra, India – 400020.

As per the financials filed for FY 2024, the company reported a revenue of ₹7.52 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net loss of ₹2.61 Cr (net margin -34.7%) and EBITDA of -₹2.13 Cr (EBITDA margin -28.4%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 23% over five years.

The company is associated with 1 brand: Spectrum Clinical Research. As per MCA filings, the company has open charges of ₹49.53 Lakh and satisfied charges of ₹85.28 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.

Spectrum Clinical Research Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0068037). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website spectrumcr.com.

Company details

CIN U73200MH2006PTC162777
Registration Number 162777
Incorporation Date 22 June 2006
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-19-0068037
Key People
Viral Chittaranjan Shah Additional Director Vimal Chandubhai Gadhiya Director

Recognitions & Rankings of Spectrum Clinical Research

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-MH-19-0068037

Contact details

Spectrum Clinical Research Private Limited's registered office is in Mumbai, Maharashtra. Its website is spectrumcr.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    spectrumcr.com
  • Registered Address
    501 5th Floor 37 Kshamalaya New Marine Lines, Mumbai, Maharashtra, India – 400020
  • Industry
    Pharma, Pharma Contract R&D

To see the full contact details of Spectrum Clinical Research Private Limited, buy the company report.

Comprehensive company report
Spectrum Clinical Research Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Spectrum Clinical Research operates one associated brand: Spectrum Clinical Research. Each brand links to its own profile.

BrandDescriptionWebsite
Spectrum Clinical Research
Offers patient-focused drug development and research support for pharmaceutical firms in India.spectrumcr.com

Business activity

The main business activity of Spectrum Clinical Research is professional, scientific and technical. In detail, this covers scientific research and development.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM5Scientific research and development

To see the full business activity and turnover split of Spectrum Clinical Research Private Limited, buy the company report.

Financials of Spectrum Clinical Research Private Limited

FY 2024 filings available

Spectrum Clinical Research Private Limited reported revenue of ₹7.52 Cr (up 19% YoY) for FY 2024.

Revenue · FY 2024
₹7.52 Cr ▲ 19%
Net loss · FY 2024
₹2.61 Cr margin -34.7%
EBITDA · FY 2024
-₹2.13 Cr margin -28.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 19%
3 years · compounded
▼ 5%
5 years · compounded
▲ 23%
EBITDA CAGR growth
1 year
▼ 42%
3 years · compounded
▼ 58%
5 years · compounded
▼ 45%

Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 19% growth in the latest year. EBITDA fell 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹2.13 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹2.61 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin-28.4%
Net Profit Margin-34.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Spectrum Clinical Research Private Limited, buy the company report.

Board of directors of Spectrum Clinical Research Private Limited

Spectrum Clinical Research has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Viral Chittaranjan Shah
Also directs: Fresh and Green Hydroponics LLP, First Health Care Private Limited, Spectrum Medical & Diagnostics Private Limited and 1 more
Additional Director12 Feb 20224 Years 8 MonthsCurrent
Vimal Chandubhai Gadhiya
Also directs: Manish Estates Private Limited, Veena Properties Private Limited
Director16 Aug 20233 Years 2 MonthsCurrent
View all directors

Auditor

Spectrum Clinical Research Private Limited is audited by Atul Singh & Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Atul Singh & AssociatesFY 2023144762W

Shareholding

The shareholding of Spectrum Clinical Research Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Spectrum Clinical Research Private Limited, buy the company report.

Charges & borrowings

Open charges
₹49.53 Lakh
Satisfied charges
₹85.28 Lakh
Breakdown by lending institutions
Yes Bank Limited₹0.23 Cr
Bank of India₹0.19 Cr
Others₹0.07 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
27 Dec 2023100875608Bank of India₹19 LakhOpen
14 Jun 2022100581746Others₹7.43 LakhOpen
22 Aug 2016100051767Yes Bank Limited₹23.09 LakhOpen
02 May 201410495916Syndicate Bank₹50 LakhSatisfied
05 Feb 201410481203Syndicate Bank₹13.6 LakhSatisfied

To see the full charge records of Spectrum Clinical Research Private Limited, buy the company report.

Total charge records: 6 View all charges

MSME payment delays

Spectrum Clinical Research Private Limited has 2 MSME Form 1 returns on record between 2019 and 2020, listing 15 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 5)

SupplierAmount dueDue sinceReported on
an individual supplier
Medvision Biomedicals Private Limited
Spectrum Clinical Research Private Limited
an individual supplier
Rahul Pharma

To see the full MSME payment records of Spectrum Clinical Research Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

GST

Spectrum Clinical Research has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAKCS0174Q1ZQMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Spectrum Clinical Research Private Limited, buy the company report.

Recent activity

Spectrum Clinical Research Private Limited has 9 board changes on record since 2008: 2 appointments and 7 cessations. The latest: Parul Viral Shah ceased to be Director on 16 Aug 2023.

AGM
Spectrum Clinical Research Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Spectrum Clinical Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Bank Of India amounted to Rs. 19.00 Lakh with Charge ID 100875608 was registered on 27 Dec 2023.
Ceased
Parul Viral Shah ceased to be Director.
Appointed
Vimal Chandubhai Gadhiya was appointed as Director.
Charges
A charge with Others amounted to Rs. 7.43 Lakh with Charge ID 100581746 was registered on 14 Jun 2022.
Ceased
Rishita Viral Shah ceased to be Director.
Appointed
Viral Chittaranjan Shah was appointed as Additional Director.
Charges
A charge registered on 05 Feb 2014 via Charge ID 10481203 with Syndicate Bank was fully satisfied on 14 Nov 2019.
Ceased
Chittaranjan Damodardas Shah ceased to be Additional Director.
Charges
A charge registered on 02 May 2014 via Charge ID 10495916 with Syndicate Bank was fully satisfied on 27 May 2019.
Ceased
Dhimant Navin Sheth ceased to be Director.

9 earlier events are in the company report.

Frequently asked questions

Spectrum Clinical Research is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 22 June 2006 (20+ years old) and is registered under CIN U73200MH2006PTC162777.

Spectrum Clinical Research has 2 current directors:

The latest financial statements of Spectrum Clinical Research on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Spectrum Clinical Research is 27AAKCS0174Q1ZQ, registered in Maharashtra.

The CIN (Corporate Identification Number) of Spectrum Clinical Research is U73200MH2006PTC162777. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Spectrum Clinical Research has 1 court case on record: 1 filed against it.

Spectrum Clinical Research was incorporated on 22 June 2006, making it 20+ years old. It is registered with the Registrar of Companies, Mumbai.

Parul Viral Shah ceased to be Director on 16 Aug 2023. Vimal Chandubhai Gadhiya was appointed as Director on 16 Aug 2023. Rishita Viral Shah ceased to be Director on 13 Feb 2022. Spectrum Clinical Research has 9 board changes on record in total.

Yes, Spectrum Clinical Research is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0068037).

Spectrum Clinical Research has 2 MSME Form 1 returns on record between 2019 and 2020, listing 15 overdue payments to 5 micro and small suppliers. The latest return was filed on 19 Oct 2020.

Spectrum Clinical Research can be reached through the website spectrumcr.com. Its registered office is in Mumbai, Maharashtra, India.